The prevalence of<unk> <unk> <unk>  mellitus (DM) is well studied in the United States and other developed countries. However, worldwide there is a large variation in the results of the population studies in developing countries and particularly in rural areas with poor access to healthcare. For this reason,<unk>  is estimated to be undiagnosed in approximately 50% of adults worldwide. In the United States, African Americans, Mexican Americans, American Indians and non-Hispanic blacks are at a higher risk of developing<unk> <unk> <unk>  compared to non-Hispanic whites. It is more prevalent among those older than 65 years, although there is a growing trend of childhood-onset of the disease. In<unk> 011, 335 million people were estimated to have<unk> <unk> <unk>  and that number is on a trajectory to reach over 500 million people by<unk> 050. These figures correlate with a prevalence of approximately 5000 and 7500 per 100,000 in<unk> 011 and<unk> 050, respectively.<unk> <unk> <unk>  is more prevalent among men than women and in countries with low to mid income levels compared to high income level countries. It is classified as a global epidemic that is growing in parallel to massive urbanization.
Diabetes mellitus type 2 epidemiology and demographics
Metabolic syndrome epidemiology and demographics
Diabetes mellitus type 1 epidemiology and demographics
Low density lipoprotein epidemiology and demographics
Atherosclerosis epidemiology and demographics
Chronic hypertension epidemiology and demographics
Hypoglycemia epidemiology and demographics
High density lipoprotein epidemiology and demographics